COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

COVID-19 patients with abnormal heart rhythms face a greater risk of death

"Patients and physicians need to monitor for these arrhythmias closely and treatments needs to be timely," one researcher warned. 

Thumbnail

Pfizer’s big news: Trump, Biden, stock market all react after COVID-19 vaccine performs well

Pfizer's early vaccine results could represent a key step forward in the race to finally end the COVID-19 pandemic.

Newest hydroxychloroquine data ‘do not support’ use as COVID-19 treatment

This latest analysis compared the outcomes of hospitalized COVID-19 patients treated with hydroxychloroquine and those who received a placebo. 

Thumbnail

Risk of death, disability after stroke much higher for COVID-19 patients

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests. 

Thumbnail

Just 6.9% of COVID-related clinical trials are focused on cardiovascular therapies

The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic. 

Cardiologists detail why blood clots are so common among COVID-19 patients

"In patients with COVID-19, we continue to see a relentless, self-amplifying cycle of inflammation and clotting in the body," one researcher said. 

Risk of death nearly doubles when hospitalized COVID-19 patients have a history of heart failure

A history of heart failure was also associated with longer lengths of stay and an increased risk of mechanical ventilation.

covid-19 coronavirus

Myocarditis may be less common among COVID-19 patients than previously believed

Researchers reviewed autopsy data from 22 different studies, sharing their findings in Cardiovascular Pathology.

Displaying 273 - 280 of 427

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.